Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Phase 3 data and practical implications for your protocol Phase 3 data extended the timeline to 68 weeks and pushed peak weight loss to 28.7 percent, equivalent to 71.2 pounds or 32.3 kilograms in the highest-performing participants
Phase 2 body composition substudy data using DEXA scans showed that retatrutide participants lost predominantly fat mass, with a favorable fat-to-lean mass loss ratio
Our practice is physician-owned, with each of our treatments being carefully developed under a physicians oversight for more effective, lasting results
Frequency and Format One is a weekly injection, while the other is a daily pill
The information presented here is for educational purposes and does not constitute medical advice
US$ 25.93
US$ 23.04
US$ 20.26
US$ 25.50
US$ 20.95
US$ 22.85
